Palvella Therapeutics, Inc. (PVLA)

Market Cap	135.22M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	11.22M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,082
Open	11.95
Previous Close	11.98
Day's Range	11.75 - 12.05
52-Week Range	6.20 - 22.32
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About PVLA

Palvella Therapeutics, Inc. develops and commercializes pathogenetically targeted therapies to treat patients suffering from serious and rare genetic skin diseases for which there are no FDA-approved therapies. It develops QTORIN, a patented platform that designs to generate new therapies that penetrate the deep layers of the skin to locally treat a broad spectrum of rare skin diseases. The company was incorporated in 2015 and is based in Wayne, Pennsylvania.

• Founded: 2015
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: PVLA
• Website: https://palvellatx.com